Nama's AI scorecard currently rates Stepan Hold (5.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is SCL's P/E ratio?

Stepan trades at a trailing price-to-earnings ratio of 26.2.

When does SCL report earnings?

Stepan's next scheduled report is on Feb 22, 2027. Analysts expect EPS of $0.13.

What is the SCL price target?

The median analyst price target from 1 analysts is $85.00, with a range of $85.00 – $85.00.

Is SCL Shariah compliant?

Nama's AAOIFI-style screen reads Stepan as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does SCL pay a dividend?

Yes — Stepan's dividend yield is 2.4%.

Nama Insights

Stepan (SCL)

Basic Materials · Specialty Chemicals · NYSE

Stepan (SCL) is a Basic Materials company in the Specialty Chemicals industry. It has a market capitalization of $1.52B, a trailing price-to-earnings ratio of 26.2 and a free-cash-flow yield of 1.7%. Over the most recent reported fiscal year, revenue grew 7.0% and free cash flow per share fell 35.3%. Nama's AI scorecard rates it Hold, 5.0 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Hold · 5.0/10

The sections balance. As of Nov 7, 2026.

Momentum

Rising · +43.4% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-48.2%

How far the last close sits under the highest price of the past five years.

Market cap	$1.52B
Trailing P/E	26.2
Price / book	1.3
Price / sales	0.6
FCF yield	1.7%
Dividend yield	2.4%
Gross margin	11.8%
Operating margin	3.3%
Net margin	-0.1%
Revenue growth (YoY)	+7.0%
Revenue growth (3-yr annual)	-5.6%
EPS growth (YoY)	-17.3%
FCF/share growth (YoY)	-35.3%
Beta	0.9
Exchange	NYSE
Sector	Basic Materials
Industry	Specialty Chemicals

SCL earnings

Next report: Feb 22, 2027 (Q4 2026, EPS estimate $0.13). Beat the EPS estimate in 3 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 28, 2026	$0.94	$0.73	+28.8%	$692.15M
Q2 2026	Jul 29, 2026	$1.18	$0.61	+93.4%	$684.11M
Q1 2026	Apr 28, 2026	$0.45	$0.39	+15.4%	$604.51M
Q4 2025	Feb 23, 2026	-$0.02	$0.40	-105.0%	$553.89M

SCL analyst price target

Median target $85.00 from 1 analysts, ranging $85.00 – $85.00.

Specialty Chemicals peers

Ticker	Company	Market cap	P/E
LIN	Linde	$236.54B	30.9
ECL	Ecolab	$84.33B	37.4
SHW	Sherwin-Williams	$83.13B	28.9
APD	Air Products and Chemicals	$67.88B	22.7
PPG	PPG Industries	$27.03B	15.7
IFF	International Flavors & Fragrances	$20.69B	22.3
LYB	LyondellBasell Industries	$19.63B	8.6
DD	DuPont de Nemours	$19.42B	20.9

Explore live SCL data on Nama Insights →

SCL FAQ

Is SCL a buy?: Nama's AI scorecard currently rates Stepan Hold (5.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is SCL's P/E ratio?: Stepan trades at a trailing price-to-earnings ratio of 26.2.
When does SCL report earnings?: Stepan's next scheduled report is on Feb 22, 2027. Analysts expect EPS of $0.13.
What is the SCL price target?: The median analyst price target from 1 analysts is $85.00, with a range of $85.00 – $85.00.
Is SCL Shariah compliant?: Nama's AAOIFI-style screen reads Stepan as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does SCL pay a dividend?: Yes — Stepan's dividend yield is 2.4%.